Skip to main content

Main menu

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • BJGP Open Accessibility Statement
    • Editorial Board
    • Editorial Fellowships
    • Audio Abstracts
    • eLetters
    • Alerts
    • Outreach
    • BJGP Life
    • Research into Publication Science
    • Advertising
    • Contact
    • Top 10 Research Articles of the Year
  • SPECIAL ISSUES
    • Special issue: Telehealth
    • Special issue: Race and Racism in Primary Care
    • Special issue: COVID-19 and Primary Care
    • Past research calls
  • CONFERENCE
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Alerts

Search

  • Advanced search
Intended for Healthcare Professionals
BJGP Open
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
BJGP Open
Intended for Healthcare Professionals

Advanced Search

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • BJGP Open Accessibility Statement
    • Editorial Board
    • Editorial Fellowships
    • Audio Abstracts
    • eLetters
    • Alerts
    • Outreach
    • BJGP Life
    • Research into Publication Science
    • Advertising
    • Contact
    • Top 10 Research Articles of the Year
  • SPECIAL ISSUES
    • Special issue: Telehealth
    • Special issue: Race and Racism in Primary Care
    • Special issue: COVID-19 and Primary Care
    • Past research calls
  • CONFERENCE
Research

GPs’ involvement in diagnosing, treating, and referring patients with suspected or confirmed primary cutaneous melanoma: a qualitative study

Andrea L Smith, Caroline G Watts, Samuel Robinson, Helen Schmid, Chiao-Han Chang, John F Thompson, Frances Rapport, Anne E Cust and Australian Melanoma Centre of Research Excellence Study Group
BJGP Open 2020; 4 (2): bjgpopen20X101028. DOI: https://doi.org/10.3399/bjgpopen20X101028
Andrea L Smith
1 Research Fellow, Australian Institute of Health Innovation, Macquarie University, Sydney, Australia
2 Melanoma Institute Australia, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: andrea.smith@mq.edu.au
Caroline G Watts
3 Research Fellow, Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, Australia
4 Surveillance, Epidemiology and Prevention Program, Kirby Institute, UNSW, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel Robinson
5 Research Officer, Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Schmid
6 Project Manager, Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chiao-Han Chang
7 Research Assistant, Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John F Thompson
8 Melanoma Institute Australia, Sydney, Australia
9 Emeritus Professor of Melanoma and Surgical Oncology, The University of Sydney, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frances Rapport
10 Professor of Health Implementation Science, Australian Institute of Health Innovation, Macquarie University, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne E Cust
11 Professor of Cancer Epidemiology, Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, Australia
12 Melanoma Institute Australia, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info
  • eLetters
  • PDF
Loading
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com. PLEASE NOTE: your email address will be published.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Jump to comment:

  • Understanding the patient journey is key to improving services
    Ilona Blee, Sukhjit Dhariwal and Simon Tso
    Published on: 04 May 2020
  • Published on: (4 May 2020)
    Page navigation anchor for Understanding the patient journey is key to improving services
    Understanding the patient journey is key to improving services
    • Ilona Blee, Clinical Education Fellow, Warwick Hospital, South Warwickshire NHS Foundation Trust
    • Other Contributors:
      • Sukhjit Dhariwal, Dermatology Registrar
      • Simon Tso, Consultant Dermatologist

    Dear editor,

    We read the article by Smith and colleagues with interest as it analysed a wide-range of Australian general practitioners’ involvement in melanoma patients’ journey through prevention, diagnosis, and management.(1) Early diagnosis and treatment is key to reducing mortality and morbidity of cutaneous malignant melanoma.

    The well-known theoretical Model of Total Patient Delay, after Safer(2) and Andersen(3), describes the generic pathway cancer patients could journey through from the initial step of inferring illness from their symptoms through to receiving treatments for their cancer. When Walter and colleagues analysed United Kingdom melanoma patients’ journey up to the stage of pre-treatment through the lens of the Safer-Anderson Model of Total Patient Delay,(4) they found the model of Total Patient Delay insufficient in explaining the ‘complex and dynamic nature’ of patients’ journey and proposed the alternative Model of Pathways to Treatment which is grounded by existing psychological theories.(5) The Model of Pathways to Treatment has since been applied to analysing melanoma(6) and lymphoma patients’ journeys.

    The time intervals in the Model of Pathways to Treatment begins with the appraisal interval (detection of a change to a skin lesion by patients), followed by the help-seeking interval (patients inferring illness and perceive the need to seek medical advice), the diagnostic interval (assessment, investigations, and referral by c...

    Show More

    Dear editor,

    We read the article by Smith and colleagues with interest as it analysed a wide-range of Australian general practitioners’ involvement in melanoma patients’ journey through prevention, diagnosis, and management.(1) Early diagnosis and treatment is key to reducing mortality and morbidity of cutaneous malignant melanoma.

    The well-known theoretical Model of Total Patient Delay, after Safer(2) and Andersen(3), describes the generic pathway cancer patients could journey through from the initial step of inferring illness from their symptoms through to receiving treatments for their cancer. When Walter and colleagues analysed United Kingdom melanoma patients’ journey up to the stage of pre-treatment through the lens of the Safer-Anderson Model of Total Patient Delay,(4) they found the model of Total Patient Delay insufficient in explaining the ‘complex and dynamic nature’ of patients’ journey and proposed the alternative Model of Pathways to Treatment which is grounded by existing psychological theories.(5) The Model of Pathways to Treatment has since been applied to analysing melanoma(6) and lymphoma patients’ journeys.

    The time intervals in the Model of Pathways to Treatment begins with the appraisal interval (detection of a change to a skin lesion by patients), followed by the help-seeking interval (patients inferring illness and perceive the need to seek medical advice), the diagnostic interval (assessment, investigations, and referral by clinicians) and ending with the pre-treatment interval (planning and scheduling of treatment).(5,6)

    These theoretical models have important practical applications as they provide a framework for studying potential delays in patient pathways. For example, the combined appraisal and help-seeking time intervals are highly variable for different cancers, with one study from Brazil reported 36.4% of 211 melanoma patients waited more than 6 months before their first visit to a clinician.(7) Public health campaigns enabled earlier detection of melanoma(8,9) and this is most likely to be achieved through reducing the patient appraisal and help-seeking time intervals.

    Smith and colleagues discussed the impact of clinician education on melanoma patients’ journey, especially concerning the decision to refer to secondary care and the undertaking of wide local excision by general practitioners.(1) Disappointingly, a systematic review in this area had not identified studies showing educational interventions for primary care clinicians had a statistically significant quantifiable impact on patient-centred outcomes, although education increased clinician knowledge, competence and confidence in managing melanoma.(10) Perhaps future studies evaluating clinician education initiatives should examine their impact on various time intervals within the Model of Pathways to Treatment as we found this is an under investigated area.

    In the 2018 United Kingdom national audit of cancer diagnosis,(11) 151 of 798 (18.9%) melanoma cases could be classified as having avoidable delays in patients being informed of their cancer diagnosis. Before April 2020, patients in England are expected to be informed of their cancer diagnosis within 31 days and received first treatment within 62 days of a general practitioner referral. The newly implemented Faster Diagnosis Standard(12) set the new target of 28 days for patients to be informed of their cancer diagnosis. A critical review of local care pathways and the introduction of suitable interventions is needed to address patient waiting times.(13) We further hope that the Model of Pathways to Treatment could be extended to include a treatment interval as modern day cancer treatment often involve complex neoadjuvant or adjuvant therapy, and the treatment pathway patients embark on (which could change direction at any time) is a product of the cancer therapy itself modified by the patients’ social experience of the cancer therapy, the teams delivering the care and the support structure around the patient.

    References
    1. Smith AL, Watts CG, Robinson S, Schmid H, Chang CH, Thompson JF, Rapport F, Cust AE; Australian Melanoma Centre of Research Excellence Study Group. GPs' involvement in diagnosing, treating, and referring patients with suspected or confirmed primary cutaneous melanoma: a qualitative study. BJGP Open. 2020. pii: bjgpopen20X101028. doi: 10.3399/bjgpopen20X101028.
    2. Safer MA, Tharps QJ, Jackson TC, Leventhal H: Determinants of three stages of delay in seeking care at a medical clinic. Med Care. 1979, 17: 11-29. doi:10.1097/00005650-197901000-00002.
    3. Andersen BL, Cacioppo JT: Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. Br J Soc Psychol. 1995, 34 (Pt 1): 33-52.
    4.Walter FM, Humphrys E, Tso S, Johnson M, Cohn S. Patient understand of moles and skin cancer, and factors influencing presentation in primary care: a qualitative study. BMC Fam Pract. 2010;11:62. doi: 10.1186/1471-2296-11-62.
    5. Scott SE, Walter FM, Webster A, Sutton S, Emery J. The model of pathways to treatment: conceptualization and integration with existing theory. Br J Health Psychol. 2013 Feb;18(1):45-65. doi: 10.1111/j.2044-8287.2012.02077.x
    6. Walter FM, Birt L, Cavers D, Scott S, Emery J, Burrows N, Cavanagh G, MacKie R, Weller D, Campbell C. 'This isn't what mine looked like': a qualitative study of symptom appraisal and help seeking in people recently diagnosed with melanoma. BMJ Open. 2014; 4(7):e005566. doi: 10.1136/bmjopen-2014-005566.
    7. Xavier MH, Drummond-Lage AP, Baeta C, Rocha L, Almeida AM, Wainstein AJ. Delay in cutaneous melanoma diagnosis: Sequence analyses from suspicion to diagnosis in 211 patients. Medicine (Baltimore). 2016;95(31):e4396. doi: 10.1097/MD.0000000000004396.
    8. Baade P, Coory M. Trends in melanoma mortality in Australia: 1950–2002 and their implications for melanoma control. Aust N Z J Public Health 2005; 29:383–386.
    9. Iannacone MR, Green AC. Towards skin cancer prevention and early detection: evolution of skin cancer awareness campaigns in Australia. Melanoma Manag. 2014; 1(1): 75–84.
    10. Goulart JM, Quigley EA, Dusza S, Jewell ST, Alexander G, Asgari MM, Eide MJ, Fletcher SW, Geller AC, Marghoob AA, Weinstock MA, Halpern AC; INFORMED (INternet curriculum FOR Melanoma Early Detection) Group. Skin Cancer Education for Primary Care Physicians: A Systematic Review of Published Evaluated Interventions. J Gen Intern Med. 2011; 26(9):1027-35. doi: 10.1007/s11606-011-1692-y.
    11. Swann R, McPhail S, Witt J, Shand B, Abel GA, Hiom S, Rashbass J, Lyratzopoulos G, Rubin G; National Cancer Diagnosis Audit Steering Group. Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit. Br J Gen Pract. 2018; 68(666):e63-e72. doi: 10.3399/bjgp17X694169
    12. Faster Diagnosis Standard - Diagnosing cancer earlier and faster. NHS England. URL https://www.england.nhs.uk/cancer/early-diagnosis/https://www.england.nh... [Accessed 29 April 2020]
    13. O'Brien JC, Chong BF. Reducing outpatient dermatology clinic wait times in a safety net health system in Dallas, Texas J Am Acad Dermatol. 2016; 75(3): 631–632. doi: 10.1016/j.jaad.2016.04.043

    Show Less
    Competing Interests: None declared.
Back to top
Previous ArticleNext Article

In this issue

BJGP Open
Vol. 4, Issue 2
June 2020
  • Table of Contents
  • Index by author
Download PDF
Download PowerPoint
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending BJGP Open.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
GPs’ involvement in diagnosing, treating, and referring patients with suspected or confirmed primary cutaneous melanoma: a qualitative study
(Your Name) has forwarded a page to you from BJGP Open
(Your Name) thought you would like to see this page from BJGP Open.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
GPs’ involvement in diagnosing, treating, and referring patients with suspected or confirmed primary cutaneous melanoma: a qualitative study
Andrea L Smith, Caroline G Watts, Samuel Robinson, Helen Schmid, Chiao-Han Chang, John F Thompson, Frances Rapport, Anne E Cust, Australian Melanoma Centre of Research Excellence Study Group
BJGP Open 2020; 4 (2): bjgpopen20X101028. DOI: 10.3399/bjgpopen20X101028

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
GPs’ involvement in diagnosing, treating, and referring patients with suspected or confirmed primary cutaneous melanoma: a qualitative study
Andrea L Smith, Caroline G Watts, Samuel Robinson, Helen Schmid, Chiao-Han Chang, John F Thompson, Frances Rapport, Anne E Cust, Australian Melanoma Centre of Research Excellence Study Group
BJGP Open 2020; 4 (2): bjgpopen20X101028. DOI: 10.3399/bjgpopen20X101028
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • Abstract
    • How this fits in
    • Introduction
    • Method
    • Results
    • Discussion
    • Notes
    • References
  • Figures & Data
  • Info
  • eLetters
  • PDF

Keywords

  • general practice
  • melanoma
  • qualitative research
  • diagnosis
  • treatment
  • Australia
  • primary healthcare

More in this TOC Section

  • Translating primary care to telehealth: analysis of in-person consultations on diabetes and cardiovascular disease
  • Primary care physicians’ perceptions of social determinants of health recommendations: a qualitative study
  • Variation in laboratory testing for patients with long-term conditions: a longitudinal cohort study in UK primary care
Show more Research

Related Articles

Cited By...

Intended for Healthcare Professionals

@BJGPOpen's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Latest articles
  • Authors & reviewers
  • Accessibility statement

RCGP

  • British Journal of General Practice
  • BJGP for RCGP members
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP Open
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP Open: research
  • Writing for BJGP Open: practice & policy
  • BJGP Open editorial process & policies
  • BJGP Open ethical guidelines
  • Peer review for BJGP Open

CUSTOMER SERVICES

  • Advertising
  • Open access licence

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Open Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: bjgpopen@rcgp.org.uk

BJGP Open is an editorially-independent publication of the Royal College of General Practitioners

© 2023 BJGP Open

Online ISSN: 2398-3795